Provider review
Strut Health review
A needle-free daily option for both drugs, priced per plan rather than per dose.
The semaglutide lozenge costs less than the weekly injection; the oral tirzepatide costs about a third more than its injection.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated October 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
$99/mo sema lozenge (auto-refill)
Visit Strut HealthPrice as published
Strut Health
$99/mo sema lozenge (auto-refill)
FDA warning letter · Strut Health · February 2026 · addressed to Strut Health, LLC dba Strut. Details in our review.
- Vs median
- $70/mo below the $169 median
- Market
- $59–$1,300/mo across 261 of 407
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The hardest part of taking a fraction of a dose is measuring it, and Strut sells a needle-free daily version of both drugs: a buccal lozenge for semaglutide and an oral tirzepatide. On semaglutide the needle-free format is the cheaper one, about a quarter below the weekly injection. On tirzepatide it runs the other way, and the oral version costs about a third more. Either way the price is per plan, not per dose, so a smaller dose does not lower the bill. The physician visit, shipping and follow-up care are included rather than billed alongside, and you can pause or cancel from your account with 48 hours' notice. It is asynchronous by design: some states require no phone consultation, so you may not speak to the prescriber unless you ask. It does not ship to Arkansas, the headline rates require auto-refill, and there is no published lab or monitoring program.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want needle-free semaglutide without paying a premium for it
- You are comfortable with an asynchronous review rather than a live consultation
- You want to pause or cancel without calling anyone
Look elsewhere if
- You want to speak to the prescriber before starting
- You want a one-off order — the headline rates are auto-refill rates
- You want lab work and monitoring as part of the program
What it actually costs
Price as published
$99/mo sema lozenge (auto-refill)
- Vs median
- $70/mo below the $169 median across the 261 of 407 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
159 of the 407 programs here price a small dose this way. Sells a needle-free daily version of both drugs, priced per plan rather than per dose. The semaglutide lozenge costs less than the weekly injection; the oral tirzepatide costs more than its injection.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
What it does well
- Daily lozenges of both semaglutide and tirzepatide, so a needle-free route exists for either drug
- Semaglutide by lozenge is $99/mo on auto-refill, below the $129 injection
- Free physician visits, free shipping and free follow-up care included
- Each product page prints its own monthly price before any intake
Pharmacy, labs and oversight
Strut Health does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What Strut Health publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- FDA warning letter on fileOne is on file. The disclosure and the FDA's own database are directly below.
- On file
FDA warning letter
The U.S. Food and Drug Administration issued a warning letter to Strut Health in February 2026. It is addressed to Strut Health, LLC dba Strut — search that name, not ours, to find it. We are not summarizing what it says — read it at the source. This does not change how Strut Health is listed here or whether we are paid for a click to it, and we would rather you knew both of those things at once.
How the program works
Asynchronous telehealth: a U.S.-licensed physician reviews an online intake, and some states require no phone consultation, though a call with the physician can be arranged on request. For a low-dose reader the draw is format: both molecules come as a daily lozenge as well as a weekly injection, for anyone who would rather not inject. Semaglutide is a buccal lozenge, held between cheek and gum, at $99 a month on auto-refill against $129 for the injection; tirzepatide runs the other way, $199 for the sublingual lozenge against $149 for the injection. Free physician visits, follow-up care and shipping are included rather than billed separately, and a subscription can be paused, delayed or canceled from your account with 48 hours' notice before the next order processes. It ships to every state except Arkansas, and some medications are not available in every state.
The honest cons
Every headline price requires auto-refill — the semaglutide pages say auto-refill saves 21% and 13%, so a one-off order costs more
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
- Tirzepatide by lozenge costs $50 a month more than the injection
- No microdose product and no lower price for a lower dose
- Asynchronous by design: some states require no phone consultation, so you may not speak to the prescriber unless you ask for a call
- Does not ship to Arkansas, and no published lab or monitoring program
- Canceling a subscription takes 48 hours' notice before the next order processes, and nothing is refunded once the pharmacy has processed an order
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Strut Health is one of 407 low-dose GLP-1 programs compared on this site, and 261 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Where this sits
#15 of 407
Ordered with the companies that pay us first, and Strut Health is one of them. A disclosed partition, not a score.
Compare all 407 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- Sublingual troches and drops
- Microdosing semaglutide
- What the evidence actually shows
- Microdose & reconstitution calculator
- Titration planner
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Direct Meds
From $249/mo sublingual · $297/mo injection
FDA warning letter · Direct Meds · September 2025 · addressed to directmeds.com, Inc. dba DirectMeds. Details in our review.
- Vs median
- $80/mo above the $169 median
- Market
- $59–$1,300/mo across 261 of 407
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Direct Meds review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.